Evidence map›Paper›PMID 23625726›Full record

ArticleMolecular carcinogenesis2014

Up-regulated cten by FGF2 contributes to FGF2-mediated cell migration.

Shih-Ya Hung, Yi-Ping Shih, Michelle Chen, Su Hao Lo

Abstract read
In one paragraph

Article in Molecular carcinogenesis, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. FGF2 as a Potential Tumor Suppressor in Lung Adenocarcinoma.Diagnostics (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. The role of tensins in malignant neoplasms.Archives of medical science : AMS · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Multiple pathways regulate Cten in colorectal cancer without a Tensin switch.International journal of experimental pathology · 2015
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. C-terminal tensin-like (CTEN): a promising biomarker and target for cancer.The international journal of biochemistry & cell biology · 2014
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Shih-Ya HungCenter for Tissue Regeneration and Repair, Department of Biochemistry and Molecular Medicine, University of California-Davis, Sacramento, California.
Yi-Ping Shih
Michelle Chen
Su Hao Lo
University of California, Davis · US

Funding

Training Program in Oncogenic Signals and Chromosome BiologyT32CA108459 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HEYER, WOLF-DIETRICH · 2006 to 2020
$3.6M
Role of Cten in Prostate CancerR01CA102537 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI LO, SU HAO · 2004 to 2016
$2.4M
Mechanism of DLC1-mediated tumor suppressionR01CA151366 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LO, SU HAO · 2010 to 2014
$1.5M
Role of Cten in Prostate CancerR56CA102537 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LO, SU HAO · 2009 to 2009
$240k
NCI NIH HHS CA102537NCI NIH HHS R01 CA102537NCI NIH HHS R01 CA151366NCI NIH HHS R56 CA102537NCI NIH HHS T32 CA108459
6 · The paper itself

Abstract

Cten is a focal adhesion molecule that is expressed at very low levels in most normal tissues. Nonetheless, its expression has been found to increase dramatically in many types of cancer including colorectal, breast, gastric, and pancreatic cancer, suggesting that cten may play a critical role during tumorigenesis. To study the mechanisms that induce cten expression and the function of up-regulated cten, we examined the effects of several cancer-associated growth factors and cytokines on cten expression. We found that EGF, FGF2, NGF, PDGF, TGF-β, IGF-1, IL-6, and IL-13 were able to induce cten expression in a dose- and time-dependent manner. The Mek-Erk and PI3K-Akt pathways were two main signaling cascades responsible for cten up-regulation, whereas the Jak-Stat pathway could contribute to the increase in some conditions. Since many of these factors are known to promote cell migration, we hypothesized that up-regulated cten might contribute to this process. This hypothesis was investigated in FGF2-mediated cell migration. Silencing of cten not only reduced regular cell motility but also FGF2-mediated cell migration. Overexpression of cten promoted cell migration and FGF2 treatment failed to further enhance cell migration. Our findings that (1) cten is a common downstream molecule of these cancer-associated growth factors and cytokines; and that (2) up-regulated cten modulates cell migration induced by FGF2 and likely other growth factors as well, strongly suggest that cten could be a potential downstream therapeutic target for treating cancers associated with aberrant signaling of these growth factors and cytokines.

Indexed as

Cell MovementCell Line, TumorFibroblast Growth Factor 2Gene ExpressionGene Expression Regulation, NeoplasticHumansMicrofilament ProteinsNeoplasm InvasivenessSignal TransductionTensinsUp-RegulationFibroblast Growth Factor 2Microfilament ProteinsTensinsTNS4 protein, humancell migrationctenFGF2focal adhesion

Identifiers

PMID23625726
PMCPMC4388201
OpenAlexW1532639299

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.